Download the event schedule here.


2020 Featured Speakers

Kevan Herold, M.D.
Dr. Herold is C.N.H. Long Professor of Immunobiology and Medicine (Endocrinology) at Yale University School of Medicine, is Co-Director of the Yale Diabetes Center, and is Deputy Director of the Yale Center for Clinical Investigation.

He is an expert in the field of type 1 diabetes and the analysis of beta cell function. His work focuses on translational immunology and the development of new therapies based on understanding of disease mechanisms. He has helped pioneer new therapeutic interventions to try to prevent type 1 diabetes, and has served as Principal Investigator and overseen multiple diabetes focused clinical trials sponsored by the Immune Tolerance Network, TrialNet, and other NIH consortia.

Dr. Herold received his MD from Jefferson Medical College, and received his post-doctoral training and was a Fellow at the University of Chicago.

Read more about Dr. Herold’s work here


Jessica Dunne, Ph.D.
Jessica Dunne is the director and program lead for JDRF’s prevention program, which is aimed at delaying or preventing the onset of type 1 diabetes (T1D). Dr. Dunne develops and implements research programs that address key scientific and program gaps, including the investigation of potential triggers (e.g., microbiome alteration or viral infection), biomarkers to predict risk and rate of progression, and clinical interventions to delay or prevent T1D. Recently, she has initiated work into understanding how machine learning can be applied to biological questions in T1D. She currently serves as the co-director for the T1D Consortium project, which aims for the regulatory qualification (from both the U.S. Food and Drug Administration and the European Medicines Agency) of islet autoantibodies as prognostic biomarkers for T1D disease progression in pre-symptomatic T1D patients.

Prior to joining JDRF in 2008, she was a senior scientist and manager of animal biology at Elusys Therapeutics. Dr. Dunne holds a bachelor’s degree from Johns Hopkins University and a doctorate from the University of Virginia, both in the field of biomedical engineering. 


Ashleigh Palmer
Ashleigh Palmer, co-founder and CEO of Provention Bio, Inc, is a life sciences industry entrepreneur and innovator with more than 30 years of experience and expertise in corporate strategy formulation, preclinical and clinical drug evaluation and product development and commercialization. During his career, Mr. Palmer has served as CEO for multiple biopharma companies (both private and public) and has held numerous board director and chairman positions. In addition to Provention, Mr. Palmer currently serves as a non-executive director on the board of Third Pole, a clinical-stage biopharmaceutical company developing electric generated inhaled nitric oxide for certain life-threatening and debilitating critical care and chronic cardiopulmonary conditions. 


Campbell Hutton, MSPH
Campbell Hutton is Vice President, Regulatory and Health Policy and is responsible for JDRF’s regulatory and health policy functions, including both strategy and implementation. In this capacity, she oversees the regulatory affairs and health policy teams. Ms. Hutton joined JDRF in 2009 as Director, Regulatory Affairs – Medical Devices. Prior to joining JDRF, Ms. Hutton was a Vice President, Strategic Consulting Group at Becker & Associates Consulting, a boutique scientific consulting firm in Washington, D.C. Ms. Hutton holds a bachelor’s degree in biology from Washington and Lee University and a master’s degree in public health from the Gillings School of Global Public Health at the University of North Carolina, Chapel Hill.


Rick Philbin, MBA, M.Ed.

Rick Philbin received a Bachelor of Science degree with a specialization in Athletic Training from Lock Haven University in Pennsylvania. He also has a Masters Degree in Education with an emphasis in Sports Management from East Stroudsburg University in Pennsylvania. He is a member of the National Athletic Trainers Association, American College of Sports Medicine, and the National Strength and Conditioning Association. Rick’s professional experience includes working as an athletic trainer for a Philadelphia-based sports medicine center, Pat Croce’s Sports Physical Therapists, where he rehabilitated and conditioned professional athletes from the Philadelphia 76ers and Flyers.

Rick believes education is paramount for good T1D management. As an avid exercise enthusiast with T1D, he practices tight management of his diabetes while on an insulin pump. His exercise passion is basketball and weight training.